E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/20/2005 in the Prospect News Biotech Daily.

Aksys receives further Nasdaq warning on listing

New York, Dec. 20 - Aksys, Ltd. said the Nasdaq Stock Market said it has 180 days - until June 14, 2006 - to regain compliance with the minimum $1.00 per share bid requirement, the company's second warning about its listing.

The letter said that for the last 30 business days Aksys' stock has closed below the minimum $1.00 per share level.

Aksys has already been warned in a Nov. 14 letter that it failed to comply with the $10 million minimum stockholders equity requirement.

Aksys is a Lincolnshire, Ill., producer of hemodialysis products for patients suffering from kidney failure.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.